Lecture Abstract
AB024. LA09. What extent of node sampling or dissection is appropriate?
Mediastinum
2018;
2:
AB024
(19 October 2018)
Lecture Abstract
AB023. LA08. Using CUSUM for monitoring a new program
Mediastinum
2018;
2:
AB023
(19 October 2018)
Lecture Abstract
AB022. LA07. Is there a threshold for getting over the learning curve for minimally invasive surgery for thymoma?
Mediastinum
2018;
2:
AB022
(19 October 2018)
Lecture Abstract
AB021. LA06. Management of the incidentally detected prevascular mass
Mediastinum
2018;
2:
AB021
(19 October 2018)
Lecture Abstract
AB020. LA05. Determining extent of invasion and follow-up of thymic epithelial malignancies
Mediastinum
2018;
2:
AB020
(19 October 2018)
Lecture Abstract
AB019. LA04. Approach to the prevascular mass
Mediastinum
2018;
2:
AB019
(19 October 2018)
Lecture Abstract
AB018. LA03. Technical advances of radiotherapy for thymic epithelial tumors
Mediastinum
2018;
2:
AB018
(19 October 2018)
Lecture Abstract
AB017. LA02. Minimally invasive surgery of thymic tumors
Mediastinum
2018;
2:
AB017
(19 October 2018)
Lecture Abstract
AB016. LA01. Impact of lymph node dissection on thymic malignancy: The Korean Association for Research on the Thymus (KART) Database Study
Mediastinum
2018;
2:
AB016
(19 October 2018)
Oral Abstract Session 2
AB015. OA02.06: A dosimetric comparison of VMAT and IMPT with and without aperture for thymic cancer
Mediastinum
2018;
2:
AB015
(19 October 2018)
Oral Abstract Session 2
AB014. OA02.05: The role of postoperative radiotherapy in stage II and III thymoma: a Korean multicenter database study
Mediastinum
2018;
2:
AB014
(19 October 2018)
Oral Abstract Session 2
AB013. OA02.04: MRI for the follow-up of treated thymic epithelial malignancies
Mediastinum
2018;
2:
AB013
(19 October 2018)
Oral Abstract Session 2
AB012. OA02.03: Adjuvant chemotherapy improved survival of completely resected thymic squamous cell carcinoma
Mediastinum
2018;
2:
AB012
(19 October 2018)
Oral Abstract Session 2
AB011. OA02.02: The importance of measuring acetylcholine receptor antibodies in thymomas
Mediastinum
2018;
2:
AB011
(19 October 2018)
Oral Abstract Session 2
AB010. OA02.01: Comparison of factors affecting length of stay after surgery for thymic tumors: minimally invasive vs. open surgeries
Mediastinum
2018;
2:
AB010
(19 October 2018)
Oral Abstract Session 1
AB009. OA01.09: Gene expression profile reveals new biomarker for novel diagnosis and therapy in thymic and pulmonary carcinomas
Mediastinum
2018;
2:
AB009
(19 October 2018)
Oral Abstract Session 1
AB008. OA01.08: Thymic carcinoma: preliminary data of next generation sequencing analysis
Mediastinum
2018;
2:
AB008
(19 October 2018)
Oral Abstract Session 1
AB007. OA01.07: CD70 in thymic carcinoma: a promising diagnostic marker
Mediastinum
2018;
2:
AB007
(19 October 2018)
Oral Abstract Session 1
AB006. OA01.06: Incidence and pathological features of thymomatous myasthenia gravis after thymectomy at a tertiary-level center
Mediastinum
2018;
2:
AB006
(19 October 2018)
Oral Abstract Session 1
AB005. OA01.05: Prognostic factor of T3N0M0 thymic epithelial tumor with complete resection
Mediastinum
2018;
2:
AB005
(19 October 2018)
Oral Abstract Session 1
AB004. OA01.04: Predictors of occult pleural dissemination detected intraoperatively in patients with thymic tumors
Mediastinum
2018;
2:
AB004
(19 October 2018)
Oral Abstract Session 1
AB003. OA01.03: Comparison of two assessment criteria for thymic epithelial tumors after chemoradiotherapy
Mediastinum
2018;
2:
AB003
(19 October 2018)
Oral Abstract Session 1
AB002. OA01.02: Modified subxiphoid thoracoscopic versus unilateral thoracoscopic approach for early-stage thymomas without myasthenia gravis
Mediastinum
2018;
2:
AB002
(19 October 2018)
Oral Abstract Session 1
AB001. OA01.01: Tumor size as a prognostic factor in limited stage thymic epithelial tumors: a multicenter analysis
Mediastinum
2018;
2:
AB001
(19 October 2018)
Editorial
Pembrolizumab in patients with thymic carcinoma: a cautionary tale
Mediastinum
2018;
2:
55
(18 September 2018)
Editorial
Expression patterns and prognostic value of programmed death ligand-1 and programmed death 1 in thymoma and thymic carcinoma
Mediastinum
2018;
2:
54
(11 September 2018)
iMDT Corner
Case presentations and recommendations from the October 2017 ITMIG tumor board: an international multidisciplinary team
Mediastinum
2018;
2:
53
(07 September 2018)
Editorial
Chemotherapy for advanced and metastatic thymic carcinoma
Mediastinum
2018;
2:
52
(27 August 2018)
Editorial
Where is the difficulty of a myasthenia gravis patient operation 35 years ago?—“a comparison of robotic and transsternal early stage thymoma resection by Marulli”
Mediastinum
2018;
2:
51
(23 August 2018)
Editorial
Mediastinal lymphadenectomy for thymic malignancies: the time has come
Mediastinum
2018;
2:
50
(10 August 2018)
Review Article
Thymoma and thymic carcinoma: a perspective on the NCCN clinical practice guidelines in oncology
Mediastinum
2018;
2:
49
(10 August 2018)
Case Report
Middle mediastinal paraganglioma with blood supply by branch of left coronary artery: one case report
Mediastinum
2018;
2:
48
(01 August 2018)
Preface
A big picture focus on minimally invasive thymic surgery
Mediastinum
2018;
2:
47
(26 July 2018)
Editorial
Everolimus in thymic epithelial tumors: practical considerations
Mediastinum
2018;
2:
46
(24 July 2018)
Original Article
Video-assisted thoracic surgery thymectomy: subxiphoid approach
Mediastinum
2018;
2:
45
(19 June 2018)
Review Article
Right VATS thymectomy, utilising a subxiphoid incision and the LigaSure retractable L-hook
Mediastinum
2018;
2:
44
(14 June 2018)
Review Article
The pathology of mesenchymal tumors of the mediastinum
Mediastinum
2018;
2:
42
(30 May 2018)
Editorial
Paraneoplastic autoimmune diseases in patients with thymic malignancies: a favorable, but not independent, prognostic factor
Mediastinum
2018;
2:
41
(15 May 2018)
Review Article
Extended surgical resection for stage III thymic tumors
Mediastinum
2018;
2:
40
(06 May 2018)